Wiepke Cahn

Wiepke Cahn

Dr. Wiepke Cahn

  • psychoses
  • structure and connections
  • from research to care
telefoon
+31 88 75 57110 or +31 88 75 5
email
w.cahn@umcutrecht.nl
 
Ga naar LinkedIn profiel

Biography

Dr. Wiepke Cahn has been a psychiatrist since 1996 at the University Medical Center Utrecht.  In 2003 she became assistant professor at the Rudolph Magnus Institute after obtaining her PhD titled ‘brain morphology during the early course of schizophrenia’. Since that time, she has set up and been involved in various national and international multicenter research projects, including GROUP. Until 2012 she was the chief psychiatrist for the schizophrenia programme at the UMCUtrecht. Currently, she is project leader for the Utrecht Youth Cohort which will longitudinally examine the development of psychiatric disorders. Her own research interest and activity is to unravel the underlying neurobiological mechanisms of schizophrenia through examining the overlap of psychotic disorders and other medical conditions, such as diabetes.

Dr. Cahn has been an editor of ‘Tijdschrift voor Psychiatrie’ and is currently on the board of the Dutch Psychiatric Association. She has authored more than 100 papers and book chapters and has been chief editor of ‘handboek schizofrenie’. Her non-research-based activities consist of treating patients with psychotic and bipolar disorders and she is trying to improve the outcome and quality of life of patients with a severe mental illness and their families. 

Research line and group

Research line
Schizophrenia, symptomatology and neuroimaging
Number of PhD students
N=5
Number of postdocs
N=1

Personal fellowships and awards

  • Genetic Risk and Outcome of Psychosis (GROUP): Project team members: De Haan L, Kahn RS, Cahn W, Wiersma D, Bruggeman R, Van Os, Krabbendam L. ZONMW Geestkracht and additional grants for schizophrenia research 2003 - current
  • CINS Pecans Project Lundbeck foundation (collaborator) 2009 - current
  • TOPFIT project. Diabetes Foundation; Eli Lilly Nederland ; Jansen Cilag (principal investigator) 2007-2012
  • Program International Research UMCUtrecht ‘aanvraag klein’
  • ‘Ypsilon Ster’ for the psychosis department 2010

Most recent key publications

  • van Welie H, Derks EM, Verweij KH, de Valk HW, Kahn RS, Cahn W. The prevalence of diabetes mellitus is increased in relatives of patients with a non-affective psychotic disorder. Schizophr Res. 2013 Feb;143(2-3):354-7.
  • Scheewe TW, Backx FJ, Takken T, Jörg F, van Strater AC, Kroes AG, Kahn RS, Cahn W. Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatr Scand. 2012 Oct 26
  • Scheewe TW, van Haren NE, Sarkisyan G, Schnack HG, Brouwer RM, de Glint M, Hulshoff Pol HE, Backx FJ, Kahn RS, Cahn W. Exercise therapy, cardiorespiratory fitness and their effect on brain volumes: A randomised controlled trial in patients with schizophrenia and healthy controls. Eur Neuropsychopharmacol. 2012
  • Collin G, Derks EM, van Haren NE, Schnack HG, Hulshoff Pol HE, Kahn RS, Cahn W. Symptom dimensions are associated with progressive brain volume changes in schizophrenia. Schizophr Res. 2012 Jul;138(2-3):171-6.
  • Genetic Risk and Outcome in Psychosis (GROUP) Investigators. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Arch Gen Psychiatry. 2011 Feb;68(2)